Meclizine Hydrochloride Tablets USP — Class I drug recall D-0767-2022
Terminated recall by Jubilant Cadista Pharmaceuticals, Inc., reported 2022-04-06, distributed in AR, FL, NC, OH, SC. Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Table
| Recall number | D-0767-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, United States |
| Recall initiated | 2022-03-08 |
| Classified | 2022-04-12 |
| Reported by FDA | 2022-04-06 |
| Terminated | 2022-11-15 |
| Distributed | AR, FL, NC, OH, SC |
| Quantity | 12,174 bottles |
| Reason classes | labeling |
| NDC | 59746-0121, 59746-0121-06, 59746-0121-10, 59746-0122, 59746-0122-06, 59746-0122-10 |
| Lot numbers | 22P0036 |
| Expiration dates | 2024-12 |
Product
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Reason for recall
Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0767-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.